COVID-19

VACCINE

COVID-19 Vaccine – Vaccinating everyone 12 and older

Everyone who is 12 years or older and is a Will County Resident is eligible for the vaccine. Click here to schedule an appointment.

IDPH Vaccine Distribution Phases

Fases de distribución de la vacunación

IDPH Vaccination Plan

COVID-19 Vaccine, Is it Safe?

The U.S. vaccine safety system ensures that all vaccines are as safe as possible. To learn how federal partners are working together to ensure the safety of COVID-19 vaccines click here.

COVID-19 Vaccine Recommendations

For what you need to know about how the CDC is making COVID-19 vaccine recommendations in the United States click here.

COVID-19 Vaccine Emergency Use Authorizations

Moderna EUA: Moderna has been approved for individuals 18 years and over

Pfizer EUA: Pfizer has only been approved for individuals 12 years and over

Johnson & Johnson EUA: Johnson and Johnson’s vaccine has been approved for individuals 18 years and over

COVID-19 Vaccine Adverse Effects Reporting

VAERS – Vaccine Adverse Event Reporting System

The Vaccine Adverse Effects Reporting System is co-managed by the FDA and CDC to detect rare, unusual or new adverse effects from vaccines. It’s a passive reporting system, relying on individuals to report adverse effects they experience from vaccines.
To learn more please go to www.vaers.hhs.gov

VAERS Brochure in English

VAERS Brochure en español

V-SAFE

V-safe is a smartphone-based tool (No App required) that uses text messaging and web surveys to provide personalized health check-ins after you receive a COVID-19 vaccination. Through v-safe, you can quickly tell CDC if you have any side effects after getting the COVID-19 vaccine. Depending on your answers, someone from CDC may call to check on you and get more information. And v-safe will remind you to get your second COVID-19 vaccine dose if you need one.Your participation in CDC’s v–safe makes a difference — it helps keep COVID-19 vaccines safe. To learn, please go to:

https://www.cdc.gov/coronavirus/2019-ncov/vaccines/safety/vsafe.html

https://espanol.cdc.gov/coronavirus/2019-ncov/vaccines/safety/vsafe.html

COVID-19 Vaccine FAQs

Click here for frequently asked questions about the COVID-19 Vaccine.

What are the Benefits of Getting the COVID-19 Vaccine?

To learn more about the benefits of getting the COVID-19 vaccine click here.

COVID-19 vaccination bottles on top of U.S. map

COVID-19 Vaccine Distribution

COVID-19 Vaccine Distribution Tentatively Begins the Week of December 14, 2020

Initial Priority Groups to Receive the Vaccine

It should be noted that all people are assumed susceptible to the virus. Initial populations prioritized for COVID-19 vaccination will be the following based on federal guidance and pending ACIP recommendations, all phases subject to change based on ACIP guidance:

Health Care Personnel & Residents from Long Term Care Facilities.
Essential frontline workers including first responders.
Those with high risk medical conditions and adults over 65 years of age.

Phased Approach to COVID-19 Vaccinations

The Vaccination Campaign will be a phased approach per CDC guidance. There will be a limited supply of COVID-19 vaccines in December 2020, but supply will continually increase in the weeks and months that follow.

The long-term goal
The goal is for everyone to be able to easily get a COVID-19 vaccination as soon as large quantities are available. The plan is to have several thousand vaccination providers available, including doctors’ offices, retail pharmacies, hospitals, and federally qualified health centers.

The Vaccine Manufacturer Selection and Distribution Process
Learn about how the federal government began investing in select vaccine manufacturers to help them increase their ability to quickly make and distribute a large amount of COVID-19 vaccine at hhs.gov.

View the Vaccine Distribution Process

COVID-19 Phase 1 Vaccine Distribution

Phase 1 of distribution is when there is limited/scarce supply of COVID-19 vaccine doses available. Focus initial efforts on reaching critical populations. Ensure vaccination locations selected can reach populations, manage cold chain requirements, and meet reporting requirements for vaccine supply and uptake.